drugset / Trial / NCT05749861

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

NCT05749861

Phase 1 Completed 65 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348(5).

Timeline

Start
2023-04-22
Primary completion
2023-06-07
Completion
2023-07-18

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348(5) Unknown Oral
Subject CKD-828 Unknown Oral
Subject D097 Unknown Oral
Subject D337 Unknown Oral